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Tissue engineering (TE) – the generation of artificial tissue, tailored to the specific need of a patient– 
has a high potential to successfully treat a variety of defects, irrespective of whether they are 
caused by trauma, organ failure, congenital malformations or tumors. By using artificial tissue, 
damaged tissue can be restored, replaced or improved in its function, without taking the risk of 
immunological rejection [1, 2, 3, 4].  
The general principle of manufacturing artificial tissue is based on the application of autologous 
stem cells. The cells are extracted from a patient, multiplied and seeded on a biocompatible support 
structure, which provides a structural template. Subsequently, the seeded constructs are cultivated 
in vitro. During the cultivation, a functional tissue construct is created by differentiating the seeded 
cells to the desired cell type. Thereafter, the manufactured tissue construct is ready for 
implantation (Fig. 1). 
 
Figure 1: Principle of tissue engineering 
Scheme describing the general principle of tissue engineering approaches. Stem cells (blue) are isolated from 
a patient, multiplied and subsequently cultivated on a support structure. Stems cells are differentiated to 
functional tissue cells (green). Afterward, the generated tissue construct is implanted into the patient. 
 
To effectively create functional tissue, stem cells are commonly treated with growth factors and 
cytokines [2, 5, 6]. However, to make the whole biological potential of the cells available, the 
physiologic milieu, in which stem cells differentiate to the desired cell-type in vivo, has to be 
mimicked as well as possible [7]. Accordingly, all environmental factors, which may affect cell 
differentiation must be considered in this biomimetic approach. Consequently, a cell culture has to 
be provided, for instance, with the proper oxygen concentration [8, 9, 10], mechanical [11, 12] or 
electrical [13] stimuli. Also, the support structure on which the cells are growing has to be 
manufactured according to the mechanical properties of the engineered tissue. 
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1.1. Bone tissue engineering 
The tissue engineering of bone (BTE) aims to provide substitute materials for the treatment of bone 
defects. To generate an artificial bone graft, human mesenchymal stem cells (hMSCs) or other 
osteoblast progenitor cells are seeded on biocompatible support structures and differentiated to 
osteoblasts. 
In contrast to tissue engineering of soft tissues, where hydrogels are most commonly used, solid 
scaffolds are more beneficial for BTE approaches, since they provide mechanical stability and an 
interconnecting pore structure, which is required for cell infiltration [7, 14]. The differentiation of 
hMSCs to osteoblasts is performed by treating the cells with cytokines and growth factors such as 
bone morphogenetic proteins (BMPs) [1, 15, 16, 17]. To provide a biomimetic environment, to 
efficiently create a functional bone graft, the application of mechanical stimuli [18, 19], as well as 
the cultivation at proper oxygen concentrations [20] have also to be considered. 
 
1.1.1. Artificial scaffolds for bone tissue engineering 
The current gold standard for the treatment of traumatic bone injuries is the use of bone 
substitutes harvested from the patient’s body (autografts) or a donor (allografts). Since these 
implants are essentially healthy bone, they meet all biological requirements for a bone substitute: 
viable osteogenic bone cells, an osteoconductive matrix for bone cell attachment, osteoinductive 
factors, biocompatibility, and mechanical stability. However, both methods have major drawbacks: 
harvesting an autograft requires a second operation and may result in donor-site morbidity. If 
allografts are used, there is a risk of disease transmission. [14, 21, 22] 
An alternative to auto- or allografts is the use of natural scaffolds such as xenogenic decellularized 
bone grafts (e.g. bovine femur spongiosa) as scaffolds, which can be seeded with osteoblast 
progenitor cells to generate a bone tissue equivalent. However, xenogenic materials inherit the risk 
of immune rejection and pathogen transfer [23, 24].  
The use of artificial scaffolds can circumvent these drawbacks. However, several aspects must be 
considered to create a scaffold, which meets the biological requirements and provides a biomimetic 
environment:  
Biocompatibility:  
Cells should adhere and proliferate on the scaffold and should maintain theirs in vivo cellular 
activity. Furthermore, the scaffold’s material should not trigger inflammatory reactions or release 
toxic substances. [14, 25, 26] 
Osteoconductivity:  
Cells growing on the scaffold should produce their own extracellular matrix (ECM), to allow for bone 
cell migration and new bone cell attachment [27, 28]. 
Osteoinductivity:  
The scaffold should allow for the recruitment of stem cells and other progenitor cells and induce 
the differentiation to osteogenic cells [27, 28]. 
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Mechanical stability:  
The scaffold should provide mechanical support and should cope with mechanical loading in vivo 
at the site of implantation. This is a major issue since both Young’s modulus (YM) and compressive 
strength (CST) vary considerably when cortical bone and cancellous bone are compared. While the 
YM for cortical bone is 15 – 20 GPa, the YM of cancellous bone is significantly lower at 0.1 – 2 GPa. 
The CST of cortical bone is at 100 – 200 MPa, the CST of cancellous bone is at 2 – 20 MPa, 
respectively. Consequently, the mechanical properties of scaffolds have to be optimized with 
regard to the site of implantation. [14, 26, 28] 
Pore size and porosity:  
For a scaffold for bone tissue engineering an interconnecting pore network with sufficient pore 
sizes is required, since both affect the nutrient transfer, cell migration, and angiogenesis. In closed 
pore structures, the nutrient transfer is significantly reduced. Thus, cells will not migrate into closed 
pores, resulting in cell-free structures and a less viable engineered tissue. This is also the case if 
pore diameters are significantly smaller than 100 µm. For optimum bone ingrowth, pore diameters 
within the range of 250 – 300 µm were found to yield the best results. It must be taken into 
consideration that if pores are significantly larger, the mechanical stability of the scaffold may be 
impaired. However, the main factor affecting the mechanical stability of a scaffold is the overall 
porosity. [14, 21, 26, 29] 
Degradation in vivo: 
To fully restore the function of a defective bone, the foreign scaffold material of the tissue- 
engineered bone must be replaced by host bone tissue. Artificial scaffold materials cannot be 
assimilated in the natural bone remodeling cycle. Consequently, the scaffold must degrade in vivo, 
so that space is provided in which new bone tissue can grow. These degradation processes, whether 
driven by macromolecular degradation or hydrolysis, should preferably occur at controllable 
resorption rates between 3 – 9 months. Thereby, degradation behavior can be adapted to different 
applications. [14, 25, 26, 30, 31] 
Apart from pore size and porosity, which are dependent on the design and the manufacturing 
technique, these requirements are mainly a function of the processed material. Consequently, 
several biomaterials have been researched for their use in bone tissue engineering in recent years. 
Synthetic polymers: 
Because of their excellent properties in regard of degradability, biocompatibility, and mechanical 
stability, synthetic polymer materials such as polylactic acid (PLA), polyglycolic acid (PGA) and 
polycaprolactone (PCL) have been widely used for BTE applications. Out of these polymers, PCL is 
the most commonly used material. PCL offers both osteoconductivity and osteoinductivity [25, 26]. 
Furthermore, its thermoplastic properties and its solubility in common organic solvents make it 
easily processable and accessible for up-to-date rapid prototyping manufacturing techniques [32, 
33, 34]. Like other synthetic polymers, PCL degrades in vivo by hydrolysis, with degradation times 
of approximately one year, which is significantly slower than PLA and PGA. Consequently, PCL 
maintains its mechanical stability over a longer period of time [21]. However, the degradation of 
synthetic polymers may result in the release of acidic by-products, which locally creates an acidic 
environment if by-products are not eliminated fast enough. Naturally, this can result in tissue 
responses such as inflammatory reactions [14, 25, 35, 36, 37]. 
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Bioceramics: 
Bioceramics such as hydroxyapatite (HA) or tricalcium phosphate (TCP) can be used as an 
alternative to synthetic polymers. Since HA is of the same chemical composition of the inorganic 
phase of natural bone, it naturally provides both osteoconductivity and osteoinductivity [38, 39]. 
Compared to synthetic polymers, bioceramics offer superior mechanical stability with regard to 
CST. However, the CST of ceramic scaffolds can exceed the CST of natural bone, which can result in 
stress shielding at the implantation site [40]. Also, the brittleness of ceramic scaffolds results in an 
inferior fracture toughness, which carries the risk of failure if loading limits are reached. 
Consequently, ceramic scaffolds are not suitable for load-bearing applications [21, 25, 41]. 
Composite materials: 
To minimize the drawbacks of synthetic polymers and bioceramics while maintaining their 
advantageous properties, polymers and bioceramics can be combined in a polymer-ceramic 
composite material. Consequently, composites can offer both the fracture toughness of a polymer 
and the compressive strength of the bioceramic, while offering great osteoconductivity and 
osteoinductivity, thus creating a matrix with mechanical and biological properties close to natural 
bone [25, 42, 43]. Furthermore, the acidification of the environment by by-products of the 
degradation of synthetic polymers can be buffered by basic resorption products of bioceramics 
such as HA [26, 44, 45].  
 
1.1.2. Sheet-based scaffolds for bone tissue engineering 
A main quality aspect of an engineered tissue is an even cell distribution of viable and functionally 
differentiated cells. However, for solid scaffolds, complex dynamic cell seeding methods must be 
applied to achieve even cell distributions and to avoid low initial cell densities [46, 47, 48, 49]. 
Furthermore, the assessment of cell fate after the cultivation of cells on a solid scaffold requires 
complex equipment [50] or cryosectioning of the scaffold and recompilation of the single images 
to a 3-dimensional (3D) image. Cryosectioning naturally includes fixation of the cells. As a result, 
the scaffolds cannot be used for further applications after analysis [49, 51]. To circumvent these 
drawbacks a sheet based-scaffold (SSC) concepts can be used. 
The SSC concept derives from the scaffold-free cell sheet (CS) technology. This technology is based 
on thermo-responsive tissue culture dishes, which allow for the non-invasive harvest of confluently 
growing cells as monolayers with intact ECM. These monolayers can be stacked to form a scaffold-
free 3D tissue equivalent [52, 53, 54, 55]. By using this approach, the problem of creating an 
engineered tissue with uniform cell distribution is addressed. Furthermore, the analysis of cell fate 
is facilitated, since no solid structures impede imaging even in deeper layers [53, 56]. However, the 
lack of solid structures results in inferior mechanical stability. Thus, the application of CS in BTE is 
limited to non-load-bearing, small bone defects [57]. However, cell sheets can be cultivated on solid 
scaffold structures, to generate a mechanical stable engineered bone [58, 59]. 
To provide mechanical stability, while maintaining the advantages of the CS technology, sheet-
based scaffold (SSC) concepts were developed in recent years. These concepts are based on the 
manufacturing of single solid sheets, which are inoculated and subsequently stacked to form a 3D-
cell culture (Fig. 2) [60, 61, 62].  
SSCs offer the opportunity to create solid scaffolds with even cell distributions since the distribution 
of cells can be assessed on every single sheet prior to assembling. Also, the analysis of cell fate is 
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facilitated, since the SSC can be disassembled after cultivation. Accordingly, the 3D cell culture can 
be analyzed sheet by sheet. Furthermore, it is possible to create complex engineered tissues, which 
contain more than one cell type in defined areas, when sheets inoculated with different cell-types 
are stacked or combined with hydrogel layers [63, 64].  
The manufacturing of current SSCs is mostly based on electrospinning of composite materials. 
However, electrospinning requires complex manufacturing setups. Also, the pore size of the 
manufactured grafts cannot be controlled easily and is limited to smaller pore sizes [65, 66]. Thus, 
cell migration can be lowered [60]. Also, the fine structures of electrospun grafts can result in 
inferior mechanical stability [65]. Both can hamper the generation of functional bone tissue 
equivalents significantly. 
 
Figure 2: Sheet-based scaffold concept 
The principle of sheet-based scaffold concepts, shown exemplarily for sheets manufactured of a PCL/HA 
composite material: Option A (1A, 2A): A cell suspension is seeded on a single PCL/HA sheet and cultivated 
until the sheet is homogeneously overgrown. Option B (1B, 2B): A cell sheet with intact ECM is created and 
transferred to a PCL/HA sheet. 3: Homogeneously overgrown sheets are stacked to a 3D cell culture.  
 
1.2. Impact of oxygen concentration on bone tissue engineering 
The generation of a biomimetic environment is of crucial importance for successful tissue 
engineering. An important factor, which must be considered for this approach, is the oxygen 
concentration (OC). Cells have to be supplied with sufficient levels of oxygen, since oxygen is one 
of the most critical parameters for cell survival. However, the OC does affect not only cell survival, 
but also cell differentiation [20, 67]. 
In vivo, cells are supplied with oxygen via both convection through the vascular network and 
diffusion. Since the diffusion of oxygen in tissue is limited, the distance between cells and capillaries 
rarely exceeds 200 µm [68, 69]. In native bone, a shortage of oxygen results in the accumulation of 
hypoxia-inducible factors (HIFs) in the cells. Among other things, these factors promote 
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angiogenesis by inducing the expression of the vascular endothelial growth factor, which results in 
neovascularization and thus the retrieval of a sufficient oxygen supply [20, 70].  
However, HIFs also affect the differentiation potential of osteogenic precursor cells such as hMSCs. 
If hMSCs are exposed to hypoxic conditions, and HIFs accumulate within the cells, their continuance 
in the undifferentiated state is highly promoted [20, 67, 71, 72]. This is due to the impact of HIFs 
on the expression level of many genes, including pluripotency-related genes like the Yamanaka 
factors SOX2, OCT3/4, KLF4 and c-MYC, and other stemness-related transcription factors [67, 73, 
74]. However, if normoxic conditions are restored, HIFs such as HIF-1 are inactivated by oxygen-
dependent degradation, and the differentiation potential of the stem cells is restored. This 
demonstrates the relationship between sufficient supply with oxygen and osteogenesis [75, 76]. 
Consequently, hypoxic conditions must be avoided in a tissue engineering graft if the differentiation 
of hMSCs to functional osteocytes is desired.  
Static cultivation methods are commonly used in conventional tissue engineering approaches. In 
doing so, the tissue-engineered graft is immersed in culture medium. Naturally, in a static 
cultivation setup, oxygen transport is solely dependent on passive diffusion. Due to the oxygen 
consumption of cells growing on the surface of a 3D-cell culture, and due to the limited oxygen 
diffusion, the OC will decline from the surface to the center of the 3D-cell culture. These oxygen 
gradients can possibly result in a hypoxic environment in the center of the tissue engineered graft 
[20, 77, 78]. Consequently, the size of a 3D-cell culture is highly limited for static cultivation 
approaches, if hypoxic conditions are to be avoided. 
However, the limitation of size and the generation of a hypoxic environment can be circumvented 
by cultivating the engineered tissue under dynamic conditions using a bioreactor system [79, 80, 
81]. 
 
1.3. Bioreactor systems for bone tissue engineering 
In static cultivation, poor mass transport of oxygen, nutrients and waste products can result in 
insufficient nutrient supply and in the generation of an unfavorable environment for both cell 
survival and differentiation [20, 82, 83]. Furthermore, static conditions do not represent in vivo 
conditions.  Consequently, a bioreactor system must be used for the manufacturing of native-like 
tissue, since it can provide a flow of cell culture media through a porous 3D-cell culture, in order to 
mimic the in vivo scenario of nutrient transport through blood vessels. In doing so, bioreactor 
systems cope with the limitations of static cultivation by improving the supply with nutrients and 
oxygen significantly [80, 83, 84]. Furthermore, bioreactor systems can be used for dynamic cell 
seeding procedures in order to facilitate the generation of a homogeneous initial cell distribution 
within a 3D-cell culture [85, 86, 87]. Besides the presence of viable and functional cells, even cell 
distributions are crucial for uniform tissue generation and thus critical for the quality of engineered 
tissue equivalents [5, 88]. 
To provide proper mass transport, several bioreactor systems have been developed in recent years 
[89, 90, 91, 92, 93]. Even though all of these bioreactor systems mitigate diffusional limitations, 
perfusion bioreactor systems (Fig. 3) have the highest potential to provide optimal nutrient and 
oxygen supply for the cultivation of 3D-cell cultures [81, 94, 95, 96]. Furthermore, perfusion 
bioreactors can be used to stimulate cells mechanically. By perfusing a 3D-cell culture, laminar 
shear stress is applied to the cultivated cells, while the amount of shear stress can be adjusted and 
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controlled by perfusing the 3D-cell culture at different flow velocities [19, 97]. This is a critical factor 
to be considered in BTE applications since the application of mechanical forces such as laminar 
shear stress is known to affect the differentiation behavior of hMSCs [19, 31, 98]. 
 
Figure 3: Schematic build of a perfusion bioreactor system 
The bioreactor and thus the inserted 3D cell culture is directly perfused by culture medium with the help of 
a pump system (e.g. a peristaltic pump). Consequently, improved mass transport and mechanical stimulation 
of the cells due to laminar shear forces are provided. 
 
Conventional bioreactors for suspension cell culture (e.g. stirred tank bioreactors) naturally provide 
the possibility to monitor and control crucial physiochemical conditions such as dissolved oxygen 
(pO2) or pH [99]. However, this is not the case for available perfusion bioreactor systems for 3D-cell 
cultures. While this may not be critical in case of pH – continuous perfusion and chemical buffering 
of cell culture media avoid pH shifts, due to metabolic waste products [79] – the lack of pO2 
measurement [91, 92, 93] and/or control instrumentation [100, 101] is a crucial drawback of 
currently available bioreactor systems for 3D-cell culture [102, 103].  
A bioreactor system with integrated pO2 measurement instrumentation and control offers the 
possibility for the investigation of cell fate in an oxygen controlled environment, to determine 
optimal oxygen concentrations for different applications. Furthermore, the production of implants 
for clinical use in an oxygen controlled environment could allow for the production of 
homogeneously overgrown and highly viable tissue equivalents [104]. This is because optimal 
oxygen concentrations for cell growth and differentiation can be granted throughout the whole 
cultivation period. Also, the oxygen signals can be processed (e.g. calculation of oxygen 
consumption rates) and used for on-line quality assessments [105, 106]. 
Design considerations for the development of bioreactor systems for tissue engineering in research 
and clinical applications: 
Bioreactor systems are a key technology for the investigation and manufacturing of engineered 
tissues in vitro since they offer the possibility to control environmental parameters and allow for 
automated and thus reproducible cultivation processes. For the development of a functional 
bioreactor system for tissue engineering approaches, whether for research or clinical applications, 
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the system must be designed to be safe, versatile, easy to use, to offer a biomimetic environment 
with real-time sensing and to operate reproducibly in an automated way. Furthermore, 
parallelization and compactness in size need to be considered (Table 1) [5, 83, 96, 98, 102, 107].  
Bioreactor safety is directly linked to sterile long-term operation. Consequently, the bioreactor 
should be manufactured using a bio-inert and non-corrosive material which can be sterilized by 
autoclaving (re-usable devices) or by gamma-sterilization (single-use devices), to guarantee 
sterility. Also, a tight sealing mechanism is required to prevent leakage or contamination [5, 83, 96, 
98].  
For clinical applications, versatility is mainly necessary in terms of the shape and size of a 3D-cell 
culture. If the bioreactor is adjustable to differently shaped 3D-cell cultures, an artificial bone tissue 
could, for instance, be manufactured with the exact shape of a patient’s defect, to further comply 
with the needs of personalized medicine. However, for research purposes, bioreactor systems 
which are also capable of cultivating different cell types are beneficial to investigate a multitude of 
different 3D-cell cultures [83, 102, 107]. 
The generation of a biomimetic environment is naturally the most crucial function of a bioreactor 
system. Therefore, mechanical stimuli (e.g. laminar shear forces), as well as biochemical factors 
such as proper oxygen concentrations, must be provided and maintained during cultivation. 
Furthermore, the bioreactor should provide even flow distribution, so that local gradients (e.g. of 
nutrients or shear forces) are avoided [5, 83, 102].  
Computational fluid dynamics (CFD) can be used to simulate streamlines within a bioreactor, and 
to optimize the geometry of the cultivation chamber to provide even flow distribution [19, 81]. 
However, it must be taken into consideration that these simulations must be performed for each 
3D-cell culture individually since every scaffold has an individual permeability (dependent on pore 
size, porosity, and size) [108, 109] which affects the flow distribution within the tissue-engineered 
graft. Furthermore, CFD can be used to simulate shear forces and shear force distributions [108, 
110] and is thus a very useful tool for the development and optimization of bioreactors for tissue 
engineering.  
To observe and maintain parameters like pO2 or pH at the desired level, the integration of 
measurement instrumentation is required. For the measurement of pO2 and pH, the use of 
fluorescence-based, non-invasive sensors is beneficial, since they circumvent the drawbacks of 
direct, invasive electrochemical probes (e.g. risk of contamination, analyte-consumption) [111, 
112]. Furthermore, acquired data of oxygen probes can be used to evaluate the viability – and thus 
the quality – of a manufactured tissue, since oxygen consumption can be directly linked to 
metabolic activity and cell viability [105, 106]. Thus, the assessment of engineered tissue, e.g. by 
(cryo)sectioning and staining may be circumvented, which minimizes the risk of contamination or 
cell death during the assessment period.  
To keep relevant parameters at an optimal level, the measurement instrumentation must be 
accompanied by an automated feedback mechanism, since automatization allows for higher 
reproducibility, better controllability and overall higher efficiency of the bioreactor system, which 
is a major criterion for clinical applications [5, 79, 83, 113].  
Another factor of ever-increasing importance is the possibility for multiplexing. A parallel set-up 
allows for high experimental throughput, which provides faster results, as well as time and cost 
savings. To investigate different parameters in a single run, or to display the variation between 
equally treated samples, the bioreactors of a parallelized system should operate independently. 
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This is especially the case if environmental parameters are to be controlled since this requires 
individual adjustments for every single bioreactor [5, 83, 113]. 
Having a bench-top system allows for a system which can be placed in a commercially available 
incubator system for temperature and CO2 atmosphere control [19, 81, 83]. Compact systems are 
also logistically easier to handle. This is especially important for clinical applications. The gold 
standard for tissue transport today is transportation at low temperatures [114], even though the 
properties of e.g. hMSCs can be impaired by this freeze-thaw process [115]. Also, cells are cut off 
from nutrient and oxygen supply during the transportation period, resulting in less viable implants. 
Consequently, bioreactor systems should not only be used for cultivation but also as transportation 
devices [104]. By using bioreactor systems for the transportation of engineered tissue grafts under 
optimal conditions, implants of the highest quality can be provided for clinical use. Thus, for both 
research and clinical applications, the size of a bioreactor system must be reasonably small. 
All these criteria, as well as their importance for research or clinical set-ups, are summarized in the 
table below (Table 1): 
Table 1: Design considerations for bioreactor systems for tissue engineering (adapted from [83]) 
Criteria Key elements Purpose Research Clinical 
Modeling Modeling and prediction of key parameters Characterize microenvironment +++ +++ 
System set-up Selection of chamber material 





Prevent leakage and contamination 
Accommodate various scaffold 












System size Smaller system 
 
Multiple independent-operating parallel systems 
Bench-top 
Save resources, logistically easier in case 
of transport 
Study of multiple parameters or samples 









Flow regime Appropriate level of laminar shear stress Increase mass transport, stimulate cells 




Control of oxygen levels, pH, temperature, gas levels, 
and flow rate 





Specific mechanical stimulation of scaffold for 
biomimetic in vitro cultivation 
Mimic physiological loading, control cell 
fate processes 
+++ +++ 
Sensors Dissolved oxygen, pH, temperature 
Media sampling for metabolites 
Media sampling for contaminations 
Investigate environmental parameters 
Understand metabolic requirements 







Imaging Imaging facility integrated into the bioreactor 
chamber 
Evaluation of scaffolds, cells, cell 
viability, tissue growth, and dynamics 
+ +++ 
Feedback Sensor/imaging-based control mechanism Maintain optimal conditions + +++ 
‘+’ indicates the level of importance in research or clinical set-ups; ‘+++’ represents high importance 
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1.4. Aims of the thesis 
The oxygen concentration is a key factor for cell growth and differentiation. However, the oxygen 
concentration is neglected in many experimental setups. Available bioreactor systems lack oxygen 
measurement instrumentation and/or the ability to control oxygen levels within a 3D-cell culture. 
Also, most parallelized setups do not provide independently operating bioreactors.  
To generate a platform, which allows for the cultivation and optimization of 3D-cell cultures in an 
oxygen-controlled environment as well as for the facile assessment of cell fate in 3D-cell cultures, 
we aimed to develop: 
1. A modular, parallelizable microbioreactor system, with integrated oxygen measurement 
instrumentation and the possibility to control the oxygen concentration in each 
microbioreactor individually. Furthermore, size and weight were considered. 
 
The following working packages were defined: 
 
a) Design, construction, characterization, and manufacturing of a perfusion microbioreactor 
b) Integration of measurement instrumentation 
c) Coding of a user interface and implementation of a feedback-control mechanism 
d) Development of a sterility concept 
e) Proof-of-concept experiments 
 
2. A sheet-based scaffold concept manufactured of a biocompatible, osteoinductive and 
osteoconductive polycaprolactone/hydroxyapatite composite material. To avoid drawbacks of 
electrospun SSCs, the sheet manufacturing protocol should be based on laser-cutting. The 
scaffold concept should allow for controllable pore size and porosity, facile generation of 
homogeneously overgrown scaffolds and should be able to be disassembled for facile analysis 
of cell fate. 
 
The following working packages were defined: 
 
a) Investigation of suitable settings for the manufacturing of PLC/HA sheets by laser-cutting 
b) Determination of the accuracy and the limits of the manufacturing process 
c) Characterization of the manufactured sheets (mechanical properties, element analysis) 
d) Assessment of growth and differentiation of hMSCs growing on PCL/HA sheets 
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1.5. Own contribution to this project 
 
Paper I:  
A Perfusion Bioreactor System for Cell Seeding and Oxygen-Controlled Cultivation of Three-
Dimensional Cell Cultures 
I performed the bioreactor design and optimization, except of CFD modeling. I coded the control 
software in LabView and optimized the control mechanism. I tested and established a functioning 
concept for sterilization. I conducted all the experiments and analyses. I wrote the manuscript with 
help from Robert Huber. 
 
Paper II: 
A Laser-Cutting based Manufacturing Process for the Generation of Three-Dimensional Scaffolds for 
Tissue Engineering using Polycaprolactone/Hydroxyapatite composite polymer 
I performed the optimization of the laser-cutting process, cell culture experiments, image 
processing, and statistical analyses. Mechanical testing was performed with the help of Sascha 
Schwarz, SEM, and EDX with the help of Dr. Constanze Eulenkamp. I wrote the manuscript with help 
from Robert Huber. 
 
 




There is an increasing need for bioreactor systems for tissue engineering applications that meet 
the needs of clinics. These are biomimicry, high reproducibility, safety, effectiveness, 
automatization, and transportability. For bone tissue engineering approaches, a biomimetic 
environment includes providing growth factors such as bone morphogenetic proteins and 
mechanical stimulation. Both can be provided by perfusion bioreactors, which mitigate diffusional 
limits by active mass transport. Also, the cell culture media flow provides mechanical stimulation 
by laminar shear forces. Furthermore, proper oxygen concentrations must be provided. However, 
the oxygen concentration is – even though known to be a critical factor for cell fate – neglected in 
most commercially available and tailor-made bioreactor systems. 
In order to develop a bioreactor system which fulfils these requirements, and to facilitate the 
research of cell fate in bone tissue engineering approaches, we aimed to develop a functional 
platform consisting of an automated oxygen-controlled perfusion bioreactor system and an 
innovative sheet-based scaffold concept. 
 
A parallelized perfusion microbioreactor system for automated, dynamic cell seeding and oxygen-
controlled cultivation of 3D-cell cultures 
The bioreactor system was developed according to the design considerations specified in section 
1.3.1, to fulfill the needs of both research laboratories and clinics. To provide maximal flexibility 
towards the design of the bioreactor and the corresponding cultivation chamber, the bioreactor 
system was manufactured using the rapid manufacturing techniques fused deposition modeling 
(FDM) and stereolithography (SL). The processed materials (PLA for FDM, and DentalSG resin for 
SL) were selected according to their approval as biocompatible by the Food and Drug 
Administration, to avoid toxic effects on the cultivated cells. To guarantee impermeability and thus 
long-term contamination-free cultivation, bioreactor parts, which are in contact with fluids, were 
manufactured by SL. 
The bioreactor consists of two main parts. The bottom part inherits the cell culture medium inlet 
and the cultivation chamber. The upper part inherits the cell culture medium outlet and a sensor 
port. The cultivation chamber for the 3D-cell culture is created by silicon casting and can be inserted 
into the bottom part of the bioreactor. By using silicon casting, the cultivation chamber can be 
adjusted to the shape of a 3D-cell culture. Consequently, the bioreactor is capable of preventing 
leakage flow around an inserted scaffold, regardless of its shape. 
By having the medium inlet in the bottom part of the bioreactor, the medium flow is directed 
upwards, which facilitates bubble-free operation. This is of high importance since entrapped air 
bubbles can hamper the distribution of cell culture medium within the 3D-cell culture and could 
thus result in less viable engineered tissue grafts. Also, air bubbles are a major obstacle to reliable 
oxygen measurements.  
CFD simulations were conducted to prove the bioreactor’s capability of providing even flow 
velocities within an inserted spongious bone scaffold at perfusion speeds between 10 – 250 µL/min. 
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Even flow distributions are of high importance for homogeneous mass transportation. 
Furthermore, shear force gradients are avoided, thus an equal mechanical stimulation is provided 
for each cell growing within a 3D-cell culture.  
To enable oxygen measurements, needle-type oxygen microsensors are used. When connected to 
the sensor port of the bioreactor, they enable the measurement of oxygen concentrations in the 
geometric center of the cultivated tissue-engineered graft. The oxygen concentration 
measurement allows for the determination of the oxygen consumption rate of the 3D-cell culture, 
which can indicate cell viability, growth, and differentiation status. However, the on-line 
interpretation of oxygen consumption rates is not integrated into the systems software yet. To 
minimize the risk of incorrect oxygen measurements, a PT100 thermocouple is used to determine 
the exact temperature of the inflowing cell culture medium, in order to compensate for 
temperature changes. This is of high importance since the solubility of oxygen is massively 
dependent on the temperature of the fluid. 
To control the oxygen concentration in the bioreactor, a proportional controller was used to link 
the signal of the oxygen sensor to the flow rate of the peristaltic pump used for perfusion. Using 
the established control algorithm, the perfusion speed is increased if the oxygen concentration 
drops below a pre-set level. This increase in medium flow naturally increases the oxygen mass 
transfer towards the 3D-cell culture to compensate for the oxygen consumption of the cells. 
Consequently, the oxygen concentration in the geometrical center of the cultivated construct is 
kept at a constant level. By using the developed control algorithm, the oxygen concentration can 
be kept at ‘set-point ± 0.5 %’ over a time period of several days. To keep shear forces at a reasonable 
level, the flow rate increase is capped at 250 µL/min, while the base flow rate is at 20 µL/min. 
In order to automate the control mechanism and to facilitate the overall handling of the bioreactor 
system, a software program was coded using LabView. The software is based on a while loop, which 
performs the following operations in each iteration: 1. request and process the oxygen sensor data, 
2. examine deviations between the measured oxygen concentration and the pre-set oxygen level, 
3. calculate and adjust the perfusion velocity according to the control algorithm (if necessary), 
4. display the current oxygen concentration and flow rate, and 5. write the acquired data to a log-
file. After the cultivation process, the software provides a quality assessment report, which 
summarizes time periods in which the oxygen concentration dropped below the pre-set level 
(feature not depicted in the published paper). This is of high importance for clinical applications for 
cases in which surgeons want to assess the engineered tissue quality based on oxygen data prior 
to implantation. 
An automated, dynamic cell seeding procedure was developed and incorporated in the bioreactor’s 
software to further improve the functionality of the bioreactor system, to conduct highly 
reproducible experiments, and to fully automate cultivations of 3D-cell cultures. To distribute a cell 
solution evenly on a scaffold inside of the bioreactor, the peristaltic pump of the bioreactor system 
is used to perform an oscillating flow profile. The oscillating flow is followed by a short period of 
static incubation to allow for cell adherence. Subsequently, the oxygen-controlled dynamic 
cultivation procedure is started. By using the automated, dynamic cell seeding procedure, even 
initial cell distributions can be achieved reproducibly, which is of high importance for the generation 
of tissue-engineered grafts of high quality. 
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To provide the option of multiplexing, a peristaltic pump with four individually movable channels 
was used to set up the bioreactor system. Accordingly, the bioreactor system can be used with up 
to four independently operating bioreactors. Nevertheless, the size of the bioreactor system was 
kept reasonably small. Consequently, the whole system can be set up in a bench-top incubator 
system – which can be used for temperature control, and to set up a CO2-atmosphere if necessary. 
Due to its compactness, the bioreactor system is also logistically easy to handle and therefore could 
offer the option of tissue transport under cultivation conditions. 
The following table sums up the implemented design considerations (according to section 1.3.1.) 
in the developed microbioreactor system (Table 2): 
Table 2: Implemented design considerations (according to section 1.3.1.) in the developed microbioreactor system 
Criteria Key elements Developed microbioreactor system 
Modeling Modeling and prediction of key parameters CFD modeling of flow distributions within a spongious bone scaffold 
System set-up Selection of chamber material 




DentalSG resin, approved by FDA as biocompatible 
Tight sealing using silicon gaskets 
Flexibility towards the shape of the 3D-cell culture, due to a silicon-
casted cultivation chamber 
DentalSG resin, sterilizable by autoclaving 
System size Smaller system 
 
Multiple independent-operating parallel systems 
Compact system, which can be set up in a bench-top incubator. 
System size could allow for transport under cultivation conditions 
Up to 4 independently-operating microbioreactors 
Flow regime Appropriate level of laminar shear stress Perfusion bioreactor provides mechanical stimulation by laminar 
shear forces. Flowrate is capped at 250 µL/min to keep mechanical 
stimulation at a reasonable level 
Environmental 
control 
Control of oxygen levels, pH, temperature, gas 
levels, and flow rate 




Specific mechanical stimulation of scaffold for 
biomimetic in vitro cultivation 
Mechanical stimulation is provided by the perfusion bioreactor. 
However, the flow rate is adjusted during the cultivation period. 
Thus the mechanical stimulation cannot be designated as specific  
Sensors Dissolved oxygen, pH, temperature 
Media sampling for metabolites 
Media sampling for contaminations 
Oxygen and temperature sensors are provided 
Possible but not implemented 
Possible but not implemented 
Imaging Imaging facility integrated into the bioreactor 
chamber 
Oxygen data can be used to calculate oxygen consumption rates, 
which can be linked to cell fate 
Feedback Sensor/imaging-based control mechanism Feedback mechanism based on oxygen sensor data  
 
A sheet-based polycaprolactone/hydroxyapatite composite scaffold concept for facile generation of 
artificial bone tissue grafts and assessment of cell fate 
The scaffold concept is based on the manufacturing of single sheets, which are stacked to form a 
scaffold with an interconnecting pore structure. The concept was developed according to the 
requirements of scaffolds for bone tissue engineering specified in section 1.1.1. 
In order to provide osteoinductivity, osteoconductivity, appropriate mechanical properties, and 
processability, a PCL/HA composite material was used. To manufacture the sheets for the scaffold 
production, a PCL/HA foil of 200 µm thickness was produced using an aluminum mold. The foil was 
subsequently processed by laser-cutting.  
The laser-cutting procedure was optimized to guarantee high accuracy and reproducibility. By using 
a continuous wave CO2 laser at 6 W laser power, the reproducibility of the manufacturing process 
is very high, with variations lower than 20 µm between equal structures. However, it must be noted, 
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that the laser-cutting process results in deviations between the cutting template and the resulting 
sheet due to material removal. For a cutting process at 6 W, these deviations are about 50 µm. 
Laser-cutting provides very high flexibility with regards to pore size and design. The only limitations 
are the following: resulting structures thinner than 125 µm are not reliably stable, and the smallest 
possible section which can be cut in a reliable way is approximately 40 µm in diameter.  
Since laser-cutting is a manufacturing technique, which has not been used for the generation of 
scaffolds for tissue engineering yet, the question of whether the manufacturing process alters the 
properties of the PCL/HA material in an unfavorable way has been the object of research. Therefore 
cell growth and differentiation experiments were conducted. Furthermore, element analysis was 
performed by SEM to investigate if residual aluminum particles can be found on the manufactured 
sheets. It was found that both the manufacturing, as well as the processing of the PCL/HA foil by 
laser-cutting does not interfere with the advantageous properties of the composite material. 
Aluminum particles could not be detected on the PCL/HA sheets, and both cell growth of hMSCs as 
well as the differentiation of hMSCs to osteoblasts were not impeded on PCL/HA materials 
processed by laser-cutting.  
To investigate if the manufactured sheets can be used to create 3D-cell cultures of high quality, 
single PCL/HA sheets were inoculated with hMSCs and stacked to a scaffold consisting of 50 sheets 
– resulting in a cylindrical scaffold with 10 mm in diameter and height. To guarantee for sufficient 
oxygen and nutrient supply, the SSC was cultivated under oxygen-controlled conditions using the 
developed microbioreactor system. Subsequently, the scaffold was disassembled and analyzed. 
Due to the oxygen control, the cells grew and remained viable throughout the whole scaffold. Also, 
the cells intergrew between stacked sheets, building a coherent 3D-cell culture. Consequently, the 
developed SSC concept is suitable for the generation of functional scaffolds for BTE. 
The developed sheet-based scaffold concept allows for several applications: 1. Cell seeding of single 
sheets individually prior to stacking to a scaffold. This way, the initial cell distribution is easier to 
assess and even cell distributions within the scaffold are easier to obtain. 2. Creation of hybrid 3D-
cell cultures, for example by incorporating hydrogel or cell sheets in-between PCL/HA sheets. By 
creating hybrid 3D-cell cultures, different cell types could be introduced in a 3D-cell culture in a 
very controlled way. This is especially interesting for vascularization approaches. 3. The assessment 
of cell fate after the cultivation period is facilitated to a great extent by the sheet-based design. 
Scaffolds can be disassembled easily and cell distribution, viability, and differentiation status can 
be assessed sheet by sheet without the need for sectioning techniques. 
Summarizing, the ‘platform for oxygen-controlled cultivation and investigation of 3-dimensional 
cell cultures for bone tissue engineering’ consists of a novel bioreactor system and an innovative 
scaffold concept. The developed platform allows for the rapid investigation and assessment of 3D-
cell cultures in an oxygen-controlled environment, which is of high interest for tissue engineering 
laboratories. Furthermore, it facilitates the generation of tissue equivalents of high quality, while 
offering an on-line assessment of tissue quality by the determination of the oxygen consumption 
of the cultivated 3D-cell culture. Also, the compact size of the system makes it logistically easy to 
handle.  
Ultimately, the developed platform can contribute to a faster advancement of engineering 3D-cell 
cultures in BTE applications for both research and clinic.




Es gibt einen stetig steigenden Bedarf an Bioreaktorsystemen für verschiedene Anwendungen im 
tissue engineering (TE), welche auch den Anforderungen eines klinischen Umfelds gerecht werden. 
Folgende Punkte müssen dabei in Betracht gezogen werden: Eine hohe Reproduzierbarkeit, 
Sicherheit, Automatisierbarkeit, Transportabilität und die Bereitstellung einer biomimetischen 
Umgebung. Für Letzteres muss, im Fall des tissue engineering von Knochen (BTE), die Zellkultur mit 
Wachstumsfaktoren, wie beispielsweise knochenmorphogenetischen Proteinen, behandelt 
werden. Zusätzlich müssen die Zellen mechanisch stimuliert werden. Dies kann von Perfusions-
Bioreaktoren geleistet werden. Der aktive Massentransport des Perfusions-Bioreaktors minimiert 
nicht nur den Einfluss von Diffusionslimits, der Flüssigkeitsstrom durch den Reaktor übt auch 
laminare Scherkräfte auf die Zellen aus. Darüber hinaus muss die Zellkultur mit der optimalen 
Sauerstoffkonzentration versorgt werden. Die meisten Bioreaktorsysteme – sowohl kommerziell 
verfügbare, als auch Laboraufbauten – sind jedoch nicht in der Lage Sauerstoffkonzentrationen zu 
messen, zu regeln oder für weitere Analysen zu prozessieren. 
Um ein Kultivierungs-System zu entwickeln, welches die Anforderungen des klinischen Umfelds 
erfüllt und um neue Anwendungen, wie die einfache Analyse von scaffolds im Bereich des BTE zu 
ermöglichen, wurde eine funktionelle Plattform entwickelt, welche aus einem automatisierten, 
Sauerstoff-kontrollierten Perfusions-Bioreaktorsystem und einem innovativem sheet-basierten 
scaffold-Konzepts besteht. 
 
Ein parallelisiertes Perfusions-Mikrobioreaktorsystem für die automatisierte, dynamische 
Besiedelung und die Sauerstoff-kontrollierte Kultivierung von 3D-Zellkulturen  
Das Bioreaktorsystem wurde unter Berücksichtigung der in Kapitel 1.3.1. aufgeführten 
Voraussetzungen entwickelt, um sowohl die Anforderungen von forschenden Einrichtungen, als 
auch die Anforderungen des klinischen Umfelds zu bedienen. Um die größtmögliche Flexibilität bei 
der Gestaltung des Bioreaktors und dessen Kultivierungskammer zu haben, wurden die 
Bioreaktoren mit den 3D-Druck-Technologien Schmelzschichtung (englisch: fused deposition 
modeling, FDM) und Stereolithografie gefertigt. Dabei wurden ausschließlich Materialien 
verwendet, welche von der ‚Food & Drug Administration‘ als biokompatibel zugelassen wurden, um 
toxische Effekte auf die kultivierten Zellen zu vermeiden. Um das Eindringen von Flüssigkeit in die 
gefertigten Teile zu verhindern – und somit einen kontaminationsfreien Betrieb zu gewährleisten – 
wurden Teile, welche mit Flüssigkeit in Kontakt kommen, mittels Stereolithographie gefertigt. 
Der entwickelte Bioreaktor besteht aus zwei Hauptkomponenten. In das Unterteil wird die 
Kultivierungskammer eingesetzt. Zudem befindet sich dort das Inlet für das Zellkulturmedium. Im 
Oberteil befindet sich entsprechend das Medien-Outlet, sowie eine Anschlussmöglichkeit für einen 
Sensor. Die Kultivierungsammer selbst wird aus einem 2-Komponenten-Silikon gegossen. Somit 
kann sie optimal auf die Geometrie der eingesetzten 3D-Zellkultur angepasst werden. Das 
ermöglicht die optimale Versorgung von 3D-Zellkulturen unterschiedlicher Formen, da ein Medien-
Leckstrom um die eingesetzte 3D-Kultur – unabhängig von deren Form – effektiv verhindert wird.  
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Die gewählte Anordnung der Anschlüsse für die Medienversorgung resultiert in einem aufwärts 
gerichteten Fluss durch den Bioreaktor. Dieser aufwärtsgerichtete Strom transportiert Luftblasen 
effektiv aus der Kultivierungskammer und erleichtert so einen Luftblasen-freien Betrieb. Dies ist 
wichtig, um eine verlässliche Messung der Sauerstoffkonzentration in der 3D-Zellkultur zu 
garantieren. Zudem können eingeschlossene Luftblasen Poren in der 3D-Zellkultur blockieren. 
Einzelne Bereiche werden dadurch von der Versorgung abgeschnitten, was entsprechend zu Zell-
freien Regionen und damit zu einem Gewebestück von minderer Qualität führt.  
Ein homogenes Strömungsfeld durch eine 3D-Zellkultur gewährleistet zweierlei. Erstens, eine 
gleichmäßige Versorgung der gesamten Kultur mit Nährstoffen und zweitens, eine vergleichbare 
mechanische Stimulation aller Zellen in der Kultur. Somit ist ein homogenes Strömungsfeld ein 
Muss für einen funktionellen Perfusions-Bioreaktor. Mittels CFD Simulationen wurde gezeigt, dass 
in dem entwickelten Bioreaktor eine homogene Strömungsverteilung entsteht. Dafür wurden die 
Strömungsgeschwindigkeiten in einem eingesetzten Knochen-scaffold bei Perfusionsraten 
zwischen 10 und 250 µL/min simuliert. 
Die Messung von Sauerstoffkonzentrationen im geometrischen Zentrum des Bioreaktors – und 
damit in dem der eingesetzten 3D-Zellkultur – wird durch Sauerstoff-Nadelsensoren ermöglicht. 
Die Sauerstoffmessung ermöglicht auch die Bestimmung der Sauerstoffverbrauchsrate der Kultur. 
Diese kann genutzt werden um Zellwachstum, Viabilität und den Differenzierungsstatus der Kultur 
abzuschätzen. Allerdings ist die echtzeit-Auswertung der Sauerstoffverbrauchsrate noch nicht in 
das momentane Bioreaktorsystem implementiert. Da die Sauerstoffmessung stark 
temperaturabhängig ist, wurde ein PT100-Thermoelement in das System integriert. So werden 
Temperaturschwankungen kompensiert, und eine korrekte Messung der Sauerstoffkonzentration 
garantiert. 
Für die Regelung der Sauerstoffkonzentration in der 3D-Zellkultur wurde ein Proportional-Regler 
genutzt und für den Bioreaktor optimiert. Dieser Proportional-Regler fungiert als Rückkopplung 
zwischen der gemessenen Sauerstoffkonzentration und der Perfusionsrate des Bioreaktors. 
Entsprechend des entwickelten Algorithmus wird somit der Massentransport von Sauerstoff in die 
3D-Kultur angepasst, um einer zunehmenden Sauerstoffverbrauchsrate entgegen zu wirken. So 
kann die Sauerstoffkonzentration im geometrischen Zentrum der 3D-Zellkultur über mehrere Tage 
konstant auf einem voreingestellten Level (± 0.5 %) gehalten werden. Um die wirkenden 
Scherkräfte unter einem kritischen Level zu halten, wurde die maximale Perfusionsrate auf 
250 µL/min festgesetzt, wobei die minimale Flussrate 20 µL/min beträgt. 
Zur Automatisierung des Regelalgorithmus, wurde dieser in eine Software eingebettet, welche in 
LabView programmiert wurde. Die Software basiert auf eine while-Schleife welche in jeder Iteration 
die folgenden Aufgaben ausführt: 1. Anfordern und Prozessieren der Daten des Sauerstoffsensors, 
2. Bestimmen der Abweichung zwischen Sollwert und Istwert der Sauerstoffkonzentration, 3. 
Berechnung der notwendigen Perfusionsrate und (wenn nötig) Anpassen der Perfusionsrate 
entsprechend des Regelalgorithmus, 4. Darstellung der Prozessvariablen Sauerstoffkonzentration, 
Sauerstoffverbrauchsrate und Perfusionsrate im Verlauf der Kultivierung in einem Diagramm, 5. 
Schreiben der Prozessvariablen in ein Logbuch zur Dokumentation und Analyse der Daten. Nach 
der Kultivierung kann zudem ein Bericht abgerufen werden. Dieser Bericht führ Zeitintervalle, in 
welchen die Sauerstoffkonzentration unter den Sollwert gefallen ist (nicht in der Publikation 
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beschrieben). Diese Funktion ermöglicht es einem Chirurgen die Qualität des erhaltenen 
Gewebestücks vor der Implantation anhand der Sauerstoffdaten abzuschätzen. 
Neben der Sauerstoffmessung wurde auch ein Verfahren zur dynamischen Besiedelung von 
scaffolds in dem Bioreaktor entwickelt. Hierfür wird die Peristaltikpumpe – welche im Normalfall 
für die Perfusion des Bioreaktors zuständig ist – genutzt, um einen oszillierenden Fluss an den 
Bioreaktor anzulegen. Über dieses Flussprofil wird eine Zellkultur-Lösung gleichmäßig auf einem 
scaffold verteilt. Anschließend wird die Kultur für eine kurze Zeit statisch inkubiert, damit die Zellen 
an das scaffold adhärieren können. Um die Funktionalität des Bioreaktorsystems zu erhöhen, die 
Reproduzierbarkeit zu steigern und um vollautomatisierte Kultivierungsprozesse zu ermöglichen, 
wurde dieses Verfahren in die Software des Bioreaktorsystems integriert. So können automatisiert 
homogene Zellverteilungen erreicht werden, was von großer Bedeutung für die Herstellung von 
hochqualitativen Gewebestücken ist. 
Um mehrere Bioreaktoren in einem parallelisierten Setup betreiben zu können wurde eine 
Peristaltikpumpe mit vier unabhängigen Kanälen verwendet. Entsprechend können bis zu vier 
individuell regelbare Bioreaktoren gleichzeitig genutzt werden. Dabei wurde darauf geachtet, auch 
das parallelisierte Setup möglichst kompakt zu halten. So kann das gesamte System in einem 
handelsüblichen Tisch-Inkubator betrieben werden, wobei der Inkubator zur Temperaturregelung 
– und wenn nötig zur Einregelung einer CO2-Atmosphäre – genutzt wird. Aufgrund seiner 
kompakten Maße könnte das System auch als Option für den Transport von Gewebe unter 
Kultivierungsbedingungen in Frage kommen. 
Die folgende Tabelle fasst zusammen, wie die Anforderungen an ein Bioreaktorsystem für TE 
(entsprechend Kapitel 1.3.1.) in dem neu entwickelten System umgesetzt wurden (Tabelle 3): 
Tabelle 3: Umgesetzte Anforderungen (entsprechend Kapitel 1.3.1) in dem neu entwickelten Bioreaktorsystem 
Anforderung Hautpelemente Umsetzung im entwickelten Bioreaktorsystem 








Autoklavierbar / Einwegartikel 
DentalSG-Harz, von der FDA als biokompatibel zugelassen 
Dichtungsringe aus Silikon garantieren dichten Verschluss 
Fertigung der Kultivierungskammer aus 2-Komponenten-Silikon ermöglicht 
hohe Flexibilität bezüglich der Form der 3D-Zellkultur  






Kompaktes System, welches in einem Tisch-Inkubator aufgebaut werden 
kann. Größe ermöglicht den einfachen Transport des Systems 
Bis zu vier Bioreaktoren, welche unabhängig voneinander arbeiten 
Strömungsform Mechanische Stimulation durch laminare 
Scherkräfte 
Über den angelegten Fluss ist der Perfusionsbioreaktor in der Lage Zellen 
mechanisch zu stimulieren. Um die Scherkräfte unter einem kritischen 
Level zu halten ist die Flussrate auf maximal 250 µL/min beschränkt. 
Kultivierungs-
parameter 
Kontrolle von Sauerstoffkonzentration, pH, 
Temperatur und Flussrate  
Die Sauerstoffkonzentration, die Temperatur und die Flussrate können im 
Bioreaktor kontrolliert werden 
Mechanische 
Stimulation 
Spezifische mechanische Stimulation der 
3D-Zellkultur für biomimetische in vitro 
Kultivierung 
Der Perfusionsbioreaktor stimuliert die Zellen durch den angelegten Fluss. 
Die Intensität der Stimulation variiert über den Verlauf der Kultivierung, da 
die Flussrate im Rahmen der Sauerstoffregelung angepasst wird 
Sensorik Sauerstoffkonzentration, pH, Temperaur 
Medienbeprobung 
Sauerstoff- und Temperatur-Sensoren sind integriert 
Möglich, aber nicht umgesetzt 
Echtzeit-
Analyse 
Echtzeit-Analyse der 3D-Zellkultur durch 
Sensorik oder bildgebende Verfahren 
Sauerstoffmessung kann genutzt werden, um die Sauerstoffverbrauchsrate 
zu berechnen. Diese korreliert mit dem Zustand der Zellkultur (Viabilität,…) 
Regelung Sensor-basierte Regelung der Kultur Anpassung der Perfusionsrate basierend auf die Sauerstoffmessung  
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Ein sheet-basiertes Polycaprolacton/Hydroxyapatit scaffold-Konzept für die vereinfachte Herstellung 
und Untersuchung von künstlichem Knochengewebe 
Das scaffold-Konzept basiert auf die Herstellung von einzelnen, flachen sheets. Diese werden 
aufeinandergestapelt, um ein dreidimensionales scaffold mit einer zusammenhängenden 
Porenstruktur zu generieren. Bei der Entwicklung des Konzepts wurden die in Kapitel 1.1.1. 
aufgeführten Anforderungen an ein funktionelles scaffold für die Herstellung von künstlichem 
Knochengewebe berücksichtigt. 
Bei der Wahl des Materials wurde auf ein Kompositmaterial aus Polycaprolacton und Hydroxyapatit 
gesetzt, da dieses Material sowohl osteokonduktiv, als auch osteoinduktiv ist. Des Weiteren hat 
PCL/HA geeignete mechanische Eigenschaften und lässt sich leicht verarbeiten. Um die sheets 
herzustellen, wurde eine 200 µm dicke PCL/HA Folie mithilfe einer Gussform aus Aluminium 
gefertigt. Die sheets wurden im Anschluss mit einem Laserschneider aus der Folie geschnitten.   
Das Laserschneiden wurde im Hinblick auf Genauigkeit und Reproduzierbarkeit optimiert. Der 
kontinuierliche CO2-Laser des Laserschneiders wurde entsprechend bei einer Leistung von 6 W 
eingesetzt. Bei dieser Einstellung konnten die Variationen zwischen gleichen Strukturen unter 
20 µm gehalten werden. Im Allgemeinen bietet Laserschneiden höchste Flexibilität in Bezug auf das 
Design der sheets. Dabei müssen jedoch die folgenden Grenzen des Prozesses berücksichtigt 
werden: Solide Strukturen sind unter einer Breite von 125 µm nicht zuverlässig stabil und die 
kleinsten reproduzierbar realisierbaren Porenstrukturen haben einen Durchmesser von ungefähr 
40 µm. Bei dem Erstellen der Vorlagen muss zudem beachtet werden, dass der Materialabtrag 
durch das Laserschneiden zu Abweichungen zwischen der Vorlage und dem resultierenden sheet 
führt (bei 6 W ungefähr 50 µm). 
Laserschneiden ist ein Herstellungsverfahren, welches noch nicht für die Herstellung von scaffolds 
für künstliches Knochengewebe genutzt wurde. Daher würde überprüft, ob das Laserschneiden die 
Eigenschaften des prozessierten Materials negativ verändert. Entsprechend wurden das 
Zellwachstum und die Differenzierung von Zellen auf dem prozessierten Material untersucht. 
Darüber hinaus wurde eine Elementanalyse durchgeführt, um zu analysieren ob Aluminiumpartikel 
nach dem Herstellungsprozess auf den sheets verbleiben. Es konnte gezeigt werden, dass sich 
sowohl die Herstellung der PCL/HA-Folie, als auch die Verarbeitung derselben nicht negativ auf die 
hervorragenden Eigenschaften des Kompositmaterials auswirkt. Weder konnten Aluminiumpartikel 
nachgewiesen werden, noch wurde das Wachstum oder die Differenzierung von hMSCs durch die 
Verarbeitung verhindert.  
Um zu zeigen, dass sich die sheets verwenden lassen um qualitativ hochwertige 3D-Zellkulturen 
herzustellen, wurden 50 runde sheets mit hMSCs besiedelt und zu einem zylindrischen scaffold mit 
einer Höhe und einem Durchmesser von 10 mm gestapelt. Anschließend wurde die 3D-Zellkultur in 
dem entwickelten Bioreaktorsystem unter Sauerstoff-kontrollierten Bedingungen kultiviert, um 
eine ausreichende Versorgung der Zellen zu gewährleisten. Anschließend wurde das scaffold 
auseinandergenommen und sheet für sheet analysiert. Durch die gute Sauerstoff- und 
Nährstoffversorgung in dem entwickelten Bioreaktor konnte eine homogene Verteilung viabler 
Zellen über das gesamte scaffold erreicht werden. Dabei konnte auch gezeigt werden, dass die 
Zellen auf den einzelnen sheets miteinander verwuchsen und so eine kohärente 3D-Zellkultur 
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bildeten. Entsprechend ist das entwickelte Konzept gut für die Herstellung von funktionellen 
scaffolds geeignet. 
Das entwickelte scaffold-Konzept kann entsprechend für verschiedene Anwendungen genutzt 
werden: 1. Für die vereinfachte Herstellung homogen überwachsener 3D-Zellkulturen, durch die 
Besiedelung von einzelnen sheets, bevor diese zu einem scaffold gestapelt werden. So kann die 
initiale Zellverteilung besser kontrolliert werden. 2. Für die Herstellung von hybriden 3D-
Zellktulturen, welche über die Kombination von soliden sheets mit Hydrogel-Schichten oder Zell-
sheets gefertigt werden können. So können komplexe Gewebestrukturen hergestellt werden, die 
sich aus verschiedenen Zelltypen zusammensetzen. Dies ist beispielsweise für die Herstellung von 
vaskularisiertem Gewebe von großem Interesse. 3. Für die vereinfachte Analyse der 3D-Zellkulturen 
nach der Kultivierung. Dadurch, dass das scaffold auseinandergenommen und sheet für sheet 
untersucht werden kann, können Zellwachstum, Zellverteilung und Differenzierungsstatus 
analysiert werden ohne die Kultur aufwändig zu schneiden. 
Zusammenfassend besteht die entwickelte Plattform aus einem neuartigen Bioreaktorsystem und 
einem innovativen scaffold-Konzept. Die Plattform ermöglicht die schnelle Untersuchung von 3D-
Zellkulturen in einer Sauerstoff-kontrollierten Umgebung. Dies ist von großem Interesse für Labors, 
welche die Herstellung von künstlichem Gewebe untersuchen. Die Plattform vereinfacht die 
Herstellung von qualitativ hochwertigem Gewebe und ist darüber hinaus in der Lage die Qualität 
des Gewebes über die bereitgestellten Sauerstoffdaten (genauer Sauerstoffverbrauchsraten) zu 
beurteilen. Des Weiteren sind die kompakten Dimensionen des Systems ein großer Vorteil, in Bezug 
auf die Mobilität des Bioreaktors. 
Durch diese Eigenschaften kann die entwickelte Plattform maßgeblich zu Fortschritten in der 
Entwicklung und Herstellung von künstlichem Knochengewebe beitragen – sowohl in forschenden 
Einrichtungen als auch im klinischen Umfeld. 
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